A Single Dose Study of MK-6194 in Healthy Chinese Participants (MK-6194-014)

NCT06821334 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: MK-6194
BIOLOGICAL: Placebo

Sponsor

Merck Sharp & Dohme LLC